Nov. 30 - Grail signs UK deal for multi-cancer screening test | 5th IVDR notified body designated, industry questions 2022 start date
IVDR notified body count inches up to 5 with TÜV Rheinland designation; CMS expands ability for hospital-level care at home ahead of holiday virus spread
New medical supply data program – Available Jan. 2021. This program aggregates distributor sales data for reporting market share and other market trends. Read now.
As competition mounts among liquid biopsy developers, the agreement gives Illumina target Grail the chance to validate its early detection tool in the real world and potentially secure access to the broader U.K. market.
The medtech notified bodies trade group urged swift action on potentially delaying the start date for the In Vitro Diagnostic Regulation if designations don't more than double by year's end.
Take your step-by-step journey toward better service with the insights from The 3 Most Important Service KPIs And How to Implement Them. Secure your copy now!
Six health systems received waivers to treat more than 60 acute conditions under the new program, which also tweaks earlier changes allowing ambulatory surgical centers to provide greater inpatient care.
MedTech Dive provides in-depth journalism and insight into the most impactful news and trends shaping medical technology. The newsletters and website cover topics such as medical devices, diagnostics, digital health, regulation/compliance, R&D, M&A and more.
Medtech Dive is a leading publication operated by Industry Dive. Our business journalists spark ideas and shape agendas for 10+ million decision makers in competitive industries.
This email is optimized for display on mobile phones. MedTech Dive: Daily Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to edwardlorilla1986.acciyo123@blogger.com. You can unsubscribe or switch to a weekly newsletter subscription anytime. See our full privacy policy.
No comments:
Post a Comment